Pokharkar, Varsha

Leveraging ndds platforms for maximising the poten-tial of ethnomedicines - Vol.53(7), July - Mumbai Indian Journal of Pharmaceutical Science 2021 - 25-30p.

Traditional medicine practised indigenously in different parts
of the world has revealed that plants possess great potential to be
developed into therapy for various ailments. Origin of about 75%
of antimicrobial and 60% of anticancer drugs approved for clinical
use from 1981 to 2002 could be traced back to nature (S. Singh
and Tripathi 2017).
Several initiatives are being undertaken worldwide in order to
leverage ethnomedicinal wisdom for the development of effective
therapies. The World Health Organization (WHO) has recognised,
emphasised and advocated the use and modernization of traditional
medicines time and again. The goals adopted by WHO in its
‘Traditional Medicine Strategy (2014-2023)’, are to harness the
potential contribution of traditional medicines (TM) to health, wellness
and people-centred healthcare and promoting the safe and effective
use of TM by regulating, researching and integrating TM products,
practitioners and practice into health systems, wherever appropriate
(WHO 2013). In India, considering the vast knowledge of indigenous
medicines, the TKDL (Traditional Knowledge Digital Library) was
introduced in 2001 with the objective for preservation, protection
and promotion of traditional, knowledge-based innovations and
practices. Ethnomedicines, if leveraged carefully, have the potential
to become the backbone of the healthcare systems worldwide soon
and for generations to come.


PHARMACEUTICS